October 21, 2013
Researchers at the University of California, San Diego School of Medicine have discovered a way to effectively deliver staurosporine (STS), a powerful anti-cancer compound that has vexed researchers for more than 30 years due to its instability in the blood and toxic nature in both healthy and cancerous cells.
September 16, 2015
Nanoparticles disguised as human platelets could greatly enhance the healing power of drug treatments for cardiovascular disease and systemic bacterial infections. These nanoparticles are capable of delivering drugs to targeted sites in the body — particularly injured blood vessels and organs infected by harmful bacteria. This targeted drug delivery greatly…
January 3, 2022
Computer simulations from UC San Diego School of Medicine reveal the action mechanism and substrate specificity of an important blood enzyme. These findings open the door for new therapeutics against cardiovascular disease, and further support a unifying theory of phospholipase function.
June 21, 2022
COVID-19 rebound following Paxlovid treatment likely due to insufficient drug exposure, UC San Diego researchers find after showing rebound patient did not show drug resistance or impaired immunity.
August 5, 2022
Brookie Best, PharmD, has been named the next dean of the Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego, succeeding James McKerrow, PhD, MD, who stepped down June 30, 2022.
November 2, 2023
Psychedelic researchers are exploring psychedelics at all levels, from the cellular to the clinical, and in a range of fields and departments, from neuroscience and pain medicine to psychology and psychiatry.
April 5, 2024
Some people have genes that protect them from alcohol abuse. An examination of databases at 23andMe reveal that those same alcohol-protective variants have associations with conditions and behaviors that may have nothing to do with alcohol.
June 17, 2013
Gordon, the newest high-performance supercomputer at the San Diego Supercomputer Center (SDSC) at the University of San Diego, California, has proven to be a boon to biologists interested in rapidly sifting through an ever-expanding amount of data.
January 23, 2020
UC San Diego School of Medicine researchers identified several genetic switches, or transcription factors, that determine whether or not liver cells produce collagen — providing a new therapeutic target for liver fibrosis.
February 1, 2018
…the impact of antibiotics on the urinary microbiome and metabolome during urinary tract infection (UTI) recovery. The project includes an art installation that uses visualizations of clinical data. Ullah is mentored by UC San Diego faculty members Rob Knight, Pieter Dorrestein, Linda Brubaker and Fonna Forman.
